By linking metabolic tumor characteristics with Cone Beam CT imaging, Jeff Geschwind advances highly selective TACE procedures. His work boosts intraprocedural decision-making, increases treatment accuracy, and strengthens clinical outcomes for hepatocellular carcinoma. https://www.slideshare.net/slideshow/dr-jeff-geschwind-a-leader-in-interventional-oncology-and-radiology-docx/275010710